financetom
Business
financetom
/
Business
/
Construction firm Montecarlo files fresh IPO papers with Sebi
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Construction firm Montecarlo files fresh IPO papers with Sebi
Oct 1, 2019 12:16 AM

Construction company Montecarlo Ltd has filed fresh IPO papers with capital markets regulator Sebi to raise an estimated Rs 550 crore.

The initial public offer comprises fresh issuance of shares worth Rs 450 crore, besides an offer for sale of up to 30 lakh equity stocks by existing shareholder Kanubhai M Patel Trust, as per the draft papers.

The company may consider a pre-IPO placement for an aggregate amount not exceeding Rs 100 crore.

"If the pre-IPO placement is undertaken, the amount raised from the pre-IPO placement will be reduced from the fresh issue," the draft prospectus noted.

According to merchant banking sources, the IPO is expected to fetch Rs 550 crore.

Proceeds of the issue will be utilised towards investment in the company's projects, to meet working capital requirements and for other general corporate purposes.

Edelweiss Financial Services, Axis Capital and HDFC Bank will manage the company's public issue.

The Ahmedabad-based firm has more than two decades of execution experience, having completed 67 EPC (engineering, procurement, construction) projects.

In May 2018, Montecarlo had approached Sebi with draft prospectus seeking its approval to raise funds through initial share-sale and in August last year, secured the market regulator's nod to float the public issue. However, the company did not launch the IPO.

As per Sebi's regulations, a firm gets one year to hit the primary market after receiving approval from the markets regulator. In case a firm fails to do so during this period, it has to refile the prospectus with Sebi seeking fresh clearance.

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
--Gap Guides For Q1 Sales of Roughly Flat With Prior Year's $3.3 Billion, vs CIQ Analyst Consensus of $3.3 Billion
--Gap Guides For Q1 Sales of Roughly Flat With Prior Year's $3.3 Billion, vs CIQ Analyst Consensus of $3.3 Billion
Mar 7, 2024
04:19 PM EST, 03/07/2024 (MT Newswires) -- Price: 20.75, Change: +1.44, Percent Change: +7.46 ...
Marvell Technology Q4 Earnings: Revenue Beat, EPS In Line, Weak Guidance Sends Shares Tumbling
Marvell Technology Q4 Earnings: Revenue Beat, EPS In Line, Weak Guidance Sends Shares Tumbling
Mar 7, 2024
Marvell Technology Inc ( MRVL ) reported fourth-quarter financial results Thursday after the close. Here’s a look at the key metrics from the quarter. Q4 Earnings: Marvell ( MRVL ) said fourth-quarter revenue increased 1% year-over-year to $1.427 billion, which beat the consensus estimate of $1.42 billion. The chip designer reported quarterly earnings of 46 cents per share, which was in line with analyst estimates....
Profound Medical Reports Q4 Net Loss of US$0.42 Per Share, Announces COO Appointment
Profound Medical Reports Q4 Net Loss of US$0.42 Per Share, Announces COO Appointment
Mar 7, 2024
04:19 PM EST, 03/07/2024 (MT Newswires) -- Profound Medical ( PROF ) reports that for Q4 2023, the company recorded, in US$, quarterly revenue of $2 million, all of it recurring, consisting of the sale of TULSA-PRO consumables, lease of medical devices, procedures and services associated with extended warranties. Q4 2023 revenue increased 60% from the $1.3 million last year....
Arcturus Therapeutics Swings to Q4 Net Loss, Revenue Drops
Arcturus Therapeutics Swings to Q4 Net Loss, Revenue Drops
Mar 7, 2024
04:22 PM EST, 03/07/2024 (MT Newswires) -- Arcturus Therapeutics ( ARCT ) reported a Q4 net loss late Thursday of $0.32 per diluted share, compared with net income of $4.33 per share a year earlier. Analysts polled by Capital IQ expected a loss of $0.86. Revenue for the quarter ended Dec. 31 was $34 million, down from $160.3 million a...
Copyright 2023-2026 - www.financetom.com All Rights Reserved